UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Chemical reviews, ISSN 0009-2665, 01/2019, Volume 119, Issue 2, pp. 1138 - 1192
Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Coordination Complexes - therapeutic use | Temperature | Oxidation-Reduction | Humans | Light | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Coordination Complexes - chemistry | Platinum - chemistry | Ruthenium - chemistry | Hydrogen-Ion Concentration | Neoplasms - drug therapy | Drugs | Side effects | Ruthenium | Toxicity | Platinum | Drug resistance | Coordination compounds | Chemical compounds | Metal complexes | Stimuli | Anticancer properties | Ruthenium compounds | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 06/2016, Volume 27, Issue 6, pp. 975 - 984
oxaliplatin | platinum | satraplatin | castration-resistant prostate cancer | cisplatin | carboplatin | Castration-resistant prostate cancer | Carboplatin | Oxaliplatin | Satraplatin | Platinum | Cisplatin | Life Sciences & Biomedicine | Oncology | Science & Technology | Phenylthiohydantoin - adverse effects | Androgen Receptor Antagonists - therapeutic use | Phenylthiohydantoin - therapeutic use | Prostatic Neoplasms, Castration-Resistant - radiotherapy | Humans | Docetaxel | Male | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Prostatic Neoplasms, Castration-Resistant - drug therapy | Radium - therapeutic use | Androgen Receptor Antagonists - adverse effects | Phenylthiohydantoin - analogs & derivatives | Prostatic Neoplasms, Castration-Resistant - pathology | Platinum Compounds - therapeutic use | Taxoids - therapeutic use | Cisplatin - therapeutic use | Cisplatin - adverse effects | Taxoids - adverse effects | Platinum Compounds - adverse effects | Index Medicus
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2009, Volume 15, Issue 7, pp. 777 - 791
Gallium | Gold complexes | Anticancer drugs | Copper-binding compounds | Metal complexes | Proteasome inhibitors | Apoptosis | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | Platinum Compounds - chemistry | Platinum Compounds - therapeutic use | Copper - chemistry | Organometallic Compounds - therapeutic use | Gallium - therapeutic use | Antineoplastic Agents - pharmacology | Molecular Structure | Organogold Compounds - chemistry | Gallium - chemistry | Organogold Compounds - therapeutic use | Copper - pharmacology | Neoplasms - enzymology | Antineoplastic Agents - chemistry | Drug Discovery | Neoplasms - drug therapy | Gallium - pharmacology | Animals | Organogold Compounds - pharmacology | Copper - therapeutic use | Organometallic Compounds - chemistry | Neoplasms - pathology | Proteasome Inhibitors | Platinum Compounds - pharmacology | Organometallic Compounds - pharmacology | Index Medicus
Journal Article
Advanced drug delivery reviews, ISSN 0169-409X, 11/2013, Volume 65, Issue 13-14, pp. 1667 - 1685
Drug delivery systems | Nanoparticle | Dendrime | Nanotube | Liposome | Micelle | Block ionomer complex | Platinum drugs | Polymer conjugate | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Nanoparticles - chemistry | Humans | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Antineoplastic Agents - administration & dosage | Platinum Compounds - chemistry | Antineoplastic Agents - chemistry | Platinum Compounds - pharmacokinetics | Drug Discovery | Drug Carriers - chemistry | Dose-Response Relationship, Drug | Platinum Compounds - therapeutic use | Organoplatinum Compounds - administration & dosage | Animals | Organoplatinum Compounds - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Molecular Structure | Platinum Compounds - administration & dosage | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - chemistry | Antimitotic agents | Drugs | Dendrimers | Chemotherapy | Analysis | Drug resistance | Antineoplastic agents | Tumors | Vehicles | Cancer | Index Medicus
Journal Article